D. A. Bennett

发表

Discriminative stimulus properties of the vasodilator, hydralazine: Differential generalization with alpha1 and alpha2 adrenoreceptor drugs

H. Lal, D. A. Bennett, 1982, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Comparison of discriminative stimuli produced by full and partial benzodiazepine agonists: pharmacological specificity.

D. A. Bennett, 1988, Psychopharmacology series.

CGS 9896: A nonbenzodiazepine, nonsedating potential anxiolytic

D. A. Bennett, B. Petrack, 1984 .

CGS 9896: agonist-antagonist benzodiazepine receptor activity revealed by anxiolytic, anticonvulsant and muscle relaxation assessment in rodents.

J. Liebman, D. A. Bennett, P. Bernard, 1985, The Journal of pharmacology and experimental therapeutics.

Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.

J. Liebman, D. Wilson, D. A. Bennett, 1989, The Journal of pharmacology and experimental therapeutics.

Naloxone‐induced reversal of clonidine, but not hydralazine, hypotension

H. Lal, D. A. Bennett, E. Elko, 1982 .

CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.

J. Lehmann, D. A. Bennett, D. Murphy, 1987, The Journal of pharmacology and experimental therapeutics.

Pentylenetetrazol discriminative stimuli are selective for identifying benzodiazepine receptor modulating agents

D. A. Bennett, Douglas E. Wilson, 1989 .

A comparison of PCP-like compounds for NMDA antagonism in two in vivo models.

D. A. Bennett, P. Bernard, C. L. Amrick, 1988, Life sciences.

Anxiolytic properties of certain annelated [1,2,4]triazolo[1,5-c]pyrimidin-5(6H)-ones.

D. A. Bennett, D. Murphy, J. L. Hyun, 1991, Journal of medicinal chemistry.

Biochemical and pharmacological characterization of the putative dopamine autoreceptor agonist benzopyranopyridine, CGS 15873A

R. A. Lovell, J. Liebman, M. Williams, 1989 .

Pharmacology of the pyrazolo-type compounds: Agonist, antagonist and inverse agonist actions

D. A. Bennett, 1987, Physiology & Behavior.

2-Amino-7-phosphonoheptanoic acid (AP7) produces discriminative stimuli and anticonflict effects similar to diazepam.

D. A. Bennett, C. L. Amrick, 1986, Life sciences.

Pharmacological characterization of CGS 17867A as a benzodiazepine receptor agonist devoid of limiting behavioral effects

J. Liebman, K. Klebs, M. Schmutz, 1987 .

Home cage pretreatment with diazepam: effects on subsequent conflict testing and rotorod assessment.

D. A. Bennett, C. L. Amrick, 1987, The Journal of pharmacology and experimental therapeutics.

N-methyl-D-aspartate produces discriminative stimuli in rats.

D. A. Bennett, C. L. Amrick, 1987, Life sciences.

Behavioral pharmacological profile of CGS 9895: A novel anxiomodulator with selective benzodiazepine agonist and antagonist properties

J. Liebman, D. A. Bennett, P. Bernard, 1985 .

The non-sedating anxiolytic CGS 9896 produces discriminative stimuli that may be related to an anxioselective effect.

D. A. Bennett, 1985, Life sciences.

Comparison of the actions of trimethadione and chlordiazepoxide in animal models of anxiety and benzodiazepine receptor binding

H. Lal, D. A. Bennett, S. Fielding, 1982, Neuropharmacology.

CGS 20625, a novel pyrazolopyridine anxiolytic.

M. Williams, M. Schmutz, D. Wilson, 1989, The Journal of pharmacology and experimental therapeutics.

Discriminative stimulus properties of the vasodilator, hydralazine: Differential generalization with alpha1 and alpha2 adrenoreceptor drugs

H. Lal, D. A. Bennett, 1982, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Effectiveness of Nantradol in Blocking Narcotic Withdrawal Signs Through Nonnarcotic Mechanisms

H. Lal, D. A. Bennett, G. Shearman, 1981, Journal of clinical pharmacology.

Discriminative stimuli produced by clonidine: an investigation of the possible relationship to adrenoceptor stimulation and hypotension.

H. Lal, D. A. Bennett, 1982, The Journal of pharmacology and experimental therapeutics.

CGS 19755: a novel competitive N-methyl-D-aspartate (NMDA) receptor antagonist with anticonvulsant, anxiolytic and anti-ischemic properties.

J. Liebman, P. Wood, J. Lehmann, 1990, Progress in clinical and biological research.